Multiple sclerosis trials, also abroad
506 open Multiple sclerosis trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
The same trial often runs in several countries
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis has 7 sites in Japan and runs in 21 countries. If a site near you is full, another one may still take people.
See Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis in all 21 countries